RETRACTED ARTICLE: MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia

Bing Liu, Hongye Ma, Qianqian Liu, Yang Xiao, Shimeng Pan, Huimin Zhou, Jia LiJournal of Experimental & Clinical Cancer Research 2019 · DOI · OpenAlex

Note: This article has been formally RETRACTED by the publisher. The summary below describes the research as presented in the original publication, but the findings should not be considered reliable or part of the current scientific consensus.

Abstract

These data indicated that miR-29b/Sp1/FUT4 axis promoted the malignant behaviors of LSCs by regulating fucosylated CD44 via Wnt/β-catenin pathway. Identifying LSCs surface markers and targeting LSCs were important for the development of potential therapies in AML.

Introduction

Acute myeloid leukemia (AML) is characterized by the presence of leukemia stem cells (LSCs), a small population of cells resistant to standard chemotherapy and responsible for disease relapse. Aberrant glycosylation, particularly fucosylation (the addition of fucose sugars to proteins), has been linked to cancer malignancy. This study aimed to identify the molecular mechanisms regulating fucosylation in LSCs and its impact on their malignant behavior.

Methods

Researchers utilized AML cell lines (KG-1a and MOLM13) and clinical samples from 50 newly diagnosed AML patients. LSCs (CD34+ CD38-) were isolated using magnetic microbeads. The study employed qRT-PCR to screen 11 fucosyltransferase (FUT) genes, dual-luciferase reporter assays and ChIP-PCR to map the miR-29b/Sp1/FUT4 regulatory axis, and shRNA-mediated knockdown to assess functional changes in cell proliferation and apoptosis. In vivo validation was performed using nude mouse models to test tumor growth and response to Adriamycin (ADR).

Key Insights and Results

FUT4 as a Driver of LSC Malignancy

Among the 11 enzymes tested, FUT4 was found to be significantly upregulated in LSCs compared to non-LSCs in both KG-1a and MOLM13 cell lines. This elevated expression suggests that FUT4 is a key driver of the "stem-ness" and survival characteristics of these cells.

Figure 1: Expressional profile of FUT family in AML cell lines, highlighting the significant upregulation of FUT4 in LSCs.

The miR-29b/Sp1/FUT4 Signaling Axis

The study identified a regulatory chain where miR-29b acts as a suppressor. In LSCs, miR-29b is downregulated, which leads to the overexpression of the transcription factor Sp1. Sp1 directly binds to the FUT4 promoter, increasing its expression. This pathway ultimately leads to the fucosylation of the surface protein CD44, which activates the Wnt/β-catenin pathway, a major engine for cell growth and survival.

Clinical and Therapeutic Implications

  • Tumor Suppression: Knocking down FUT4 in LSCs significantly reduced their ability to form spheres and increased their sensitivity to chemotherapy.
  • In Vivo Efficacy: Mice injected with FUT4-depleted LSCs showed slower tumor growth and improved response to ADR.
  • Prognostic Value: High levels of Sp1 and FUT4 in patient samples were statistically linked to shorter overall survival times.

Conclusion

While the study proposes that targeting the miR-29b/Sp1/FUT4 axis could be a viable strategy for treating AML by eradicating LSCs, the retraction of the original article necessitates extreme caution. The reported findings regarding the molecular "remote control" of LSC fucosylation require independent verification to be considered part of the established scientific record.

Summary updated

Abstract

These data indicated that miR-29b/Sp1/FUT4 axis promoted the malignant behaviors of LSCs by regulating fucosylated CD44 via Wnt/β-catenin pathway. Identifying LSCs surface markers and targeting LSCs were important for the development of potential therapies in AML.
BibTeX
@article{liu2019retracted,
  author = {Bing Liu and Hongye Ma and Qianqian Liu and Yang Xiao and Shimeng Pan and Huimin Zhou and Jia Li},
  title = {{RETRACTED ARTICLE: MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia}},
  journal = {Journal of Experimental \& Clinical Cancer Research},
  year = {2019},
  doi = {10.1186/s13046-019-1179-y},
}
Figure